Drug Pipeline

Cell Infusion Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06872333
Allo HSCT for High Risk Hemoglobinopathies		 Trial arms changed: 4 -> 5
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-29 NCT07614048 Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells… Temporarily Not Available
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06412497 MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and… Severe Aplastic Anemia Recruiting
NCT06872333 Allo HSCT for High Risk Hemoglobinopathies Graft Failure Recruiting
Phase 1
NCT03354390 HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell… Kidney Cancer Active, Not Recruiting
Sponsors Running Cell Infusion Trials
Masonic Cancer Center, University of Minnesota (2) National Heart, Lung, and Blood Institute (NHLBI) (1)
Disease Areas
Kidney Cancer (1) Sickle Cell Disease (1)
Get alerts when Cell Infusion trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free